table of content
1 Introduction to Research & Analysis Reports
1.1 Recombinant DNA Technology Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Recombinant DNA Technology Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Recombinant DNA Technology Overall Market Size
2.1 Global Recombinant DNA Technology Market Size: 2022 VS 2032
2.2 Global Recombinant DNA Technology Market Size, Prospects & Forecasts: 2018-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Recombinant DNA Technology Players in Global Market
3.2 Top Global Recombinant DNA Technology Companies Ranked by Revenue
3.3 Global Recombinant DNA Technology Revenue by Companies
3.4 Top 3 and Top 5 Recombinant DNA Technology Companies in Global Market, by Revenue in 2022
3.5 Global Companies Recombinant DNA Technology Product Type
3.6 Tier 1, Tier 2 and Tier 3 Recombinant DNA Technology Players in Global Market
3.6.1 List of Global Tier 1 Recombinant DNA Technology Companies
3.6.2 List of Global Tier 2 and Tier 3 Recombinant DNA Technology Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Recombinant DNA Technology Market Size Markets, 2022 & 2032
4.1.2 Therapeutic Agent
4.1.3 Vaccine
4.1.4 Biotech Crops
4.1.5 Specialty Chemicals
4.2 By Type - Global Recombinant DNA Technology Revenue & Forecasts
4.2.1 By Type - Global Recombinant DNA Technology Revenue, 2018-2023
4.2.2 By Type - Global Recombinant DNA Technology Revenue, 2024-2032
4.2.3 By Type - Global Recombinant DNA Technology Revenue Market Share, 2018-2032
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Recombinant DNA Technology Market Size, 2022 & 2032
5.1.2 Biotechnology and Pharmaceutical Companies
5.1.3 Academic & Government Research Institutes
5.1.4 Others
5.2 By Application - Global Recombinant DNA Technology Revenue & Forecasts
5.2.1 By Application - Global Recombinant DNA Technology Revenue, 2018-2023
5.2.2 By Application - Global Recombinant DNA Technology Revenue, 2024-2032
5.2.3 By Application - Global Recombinant DNA Technology Revenue Market Share, 2018-2032
6 Sights by Region
6.1 By Region - Global Recombinant DNA Technology Market Size, 2022 & 2032
6.2 By Region - Global Recombinant DNA Technology Revenue & Forecasts
6.2.1 By Region - Global Recombinant DNA Technology Revenue, 2018-2023
6.2.2 By Region - Global Recombinant DNA Technology Revenue, 2024-2032
6.2.3 By Region - Global Recombinant DNA Technology Revenue Market Share, 2018-2032
6.3 North America
6.3.1 By Country - North America Recombinant DNA Technology Revenue, 2018-2032
6.3.2 US Recombinant DNA Technology Market Size, 2018-2032
6.3.3 Canada Recombinant DNA Technology Market Size, 2018-2032
6.3.4 Mexico Recombinant DNA Technology Market Size, 2018-2032
6.4 Europe
6.4.1 By Country - Europe Recombinant DNA Technology Revenue, 2018-2032
6.4.2 Germany Recombinant DNA Technology Market Size, 2018-2032
6.4.3 France Recombinant DNA Technology Market Size, 2018-2032
6.4.4 U.K. Recombinant DNA Technology Market Size, 2018-2032
6.4.5 Italy Recombinant DNA Technology Market Size, 2018-2032
6.4.6 Russia Recombinant DNA Technology Market Size, 2018-2032
6.4.7 Nordic Countries Recombinant DNA Technology Market Size, 2018-2032
6.4.8 Benelux Recombinant DNA Technology Market Size, 2018-2032
6.5 Asia
6.5.1 By Region - Asia Recombinant DNA Technology Revenue, 2018-2032
6.5.2 China Recombinant DNA Technology Market Size, 2018-2032
6.5.3 Japan Recombinant DNA Technology Market Size, 2018-2032
6.5.4 South Korea Recombinant DNA Technology Market Size, 2018-2032
6.5.5 Southeast Asia Recombinant DNA Technology Market Size, 2018-2032
6.5.6 India Recombinant DNA Technology Market Size, 2018-2032
6.6 South America
6.6.1 By Country - South America Recombinant DNA Technology Revenue, 2018-2032
6.6.2 Brazil Recombinant DNA Technology Market Size, 2018-2032
6.6.3 Argentina Recombinant DNA Technology Market Size, 2018-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Recombinant DNA Technology Revenue, 2018-2032
6.7.2 Turkey Recombinant DNA Technology Market Size, 2018-2032
6.7.3 Israel Recombinant DNA Technology Market Size, 2018-2032
6.7.4 Saudi Arabia Recombinant DNA Technology Market Size, 2018-2032
6.7.5 UAE Recombinant DNA Technology Market Size, 2018-2032
7 Recombinant DNA Technology Companies Profiles
7.1 Monsanto Company
7.1.1 Monsanto Company Company Summary
7.1.2 Monsanto Company Business Overview
7.1.3 Monsanto Company Recombinant DNA Technology Major Product Offerings
7.1.4 Monsanto Company Recombinant DNA Technology Revenue in Global Market (2018-2023)
7.1.5 Monsanto Company Key News & Latest Developments
7.2 Roche
7.2.1 Roche Company Summary
7.2.2 Roche Business Overview
7.2.3 Roche Recombinant DNA Technology Major Product Offerings
7.2.4 Roche Recombinant DNA Technology Revenue in Global Market (2018-2023)
7.2.5 Roche Key News & Latest Developments
7.3 Biogen
7.3.1 Biogen Company Summary
7.3.2 Biogen Business Overview
7.3.3 Biogen Recombinant DNA Technology Major Product Offerings
7.3.4 Biogen Recombinant DNA Technology Revenue in Global Market (2018-2023)
7.3.5 Biogen Key News & Latest Developments
7.4 Amgen
7.4.1 Amgen Company Summary
7.4.2 Amgen Business Overview
7.4.3 Amgen Recombinant DNA Technology Major Product Offerings
7.4.4 Amgen Recombinant DNA Technology Revenue in Global Market (2018-2023)
7.4.5 Amgen Key News & Latest Developments
7.5 Novartis
7.5.1 Novartis Company Summary
7.5.2 Novartis Business Overview
7.5.3 Novartis Recombinant DNA Technology Major Product Offerings
7.5.4 Novartis Recombinant DNA Technology Revenue in Global Market (2018-2023)
7.5.5 Novartis Key News & Latest Developments
7.6 Eli Lilly and Company
7.6.1 Eli Lilly and Company Company Summary
7.6.2 Eli Lilly and Company Business Overview
7.6.3 Eli Lilly and Company Recombinant DNA Technology Major Product Offerings
7.6.4 Eli Lilly and Company Recombinant DNA Technology Revenue in Global Market (2018-2023)
7.6.5 Eli Lilly and Company Key News & Latest Developments
7.7 GenScript
7.7.1 GenScript Company Summary
7.7.2 GenScript Business Overview
7.7.3 GenScript Recombinant DNA Technology Major Product Offerings
7.7.4 GenScript Recombinant DNA Technology Revenue in Global Market (2018-2023)
7.7.5 GenScript Key News & Latest Developments
7.8 Pfizer Inc.
7.8.1 Pfizer Inc. Company Summary
7.8.2 Pfizer Inc. Business Overview
7.8.3 Pfizer Inc. Recombinant DNA Technology Major Product Offerings
7.8.4 Pfizer Inc. Recombinant DNA Technology Revenue in Global Market (2018-2023)
7.8.5 Pfizer Inc. Key News & Latest Developments
7.9 Novo Nordisk
7.9.1 Novo Nordisk Company Summary
7.9.2 Novo Nordisk Business Overview
7.9.3 Novo Nordisk Recombinant DNA Technology Major Product Offerings
7.9.4 Novo Nordisk Recombinant DNA Technology Revenue in Global Market (2018-2023)
7.9.5 Novo Nordisk Key News & Latest Developments
7.10 Sanofi
7.10.1 Sanofi Company Summary
7.10.2 Sanofi Business Overview
7.10.3 Sanofi Recombinant DNA Technology Major Product Offerings
7.10.4 Sanofi Recombinant DNA Technology Revenue in Global Market (2018-2023)
7.10.5 Sanofi Key News & Latest Developments
7.11 Merck KGaA
7.11.1 Merck KGaA Company Summary
7.11.2 Merck KGaA Business Overview
7.11.3 Merck KGaA Recombinant DNA Technology Major Product Offerings
7.11.4 Merck KGaA Recombinant DNA Technology Revenue in Global Market (2018-2023)
7.11.5 Merck KGaA Key News & Latest Developments
7.12 Profacgen
7.12.1 Profacgen Company Summary
7.12.2 Profacgen Business Overview
7.12.3 Profacgen Recombinant DNA Technology Major Product Offerings
7.12.4 Profacgen Recombinant DNA Technology Revenue in Global Market (2018-2023)
7.12.5 Profacgen Key News & Latest Developments
7.13 Biocon
7.13.1 Biocon Company Summary
7.13.2 Biocon Business Overview
7.13.3 Biocon Recombinant DNA Technology Major Product Offerings
7.13.4 Biocon Recombinant DNA Technology Revenue in Global Market (2018-2023)
7.13.5 Biocon Key News & Latest Developments
7.14 GlaxoSmithKline
7.14.1 GlaxoSmithKline Company Summary
7.14.2 GlaxoSmithKline Business Overview
7.14.3 GlaxoSmithKline Recombinant DNA Technology Major Product Offerings
7.14.4 GlaxoSmithKline Recombinant DNA Technology Revenue in Global Market (2018-2023)
7.14.5 GlaxoSmithKline Key News & Latest Developments
7.15 Cibus
7.15.1 Cibus Company Summary
7.15.2 Cibus Business Overview
7.15.3 Cibus Recombinant DNA Technology Major Product Offerings
7.15.4 Cibus Recombinant DNA Technology Revenue in Global Market (2018-2023)
7.15.5 Cibus Key News & Latest Developments
7.16 Horizon Discovery Group
7.16.1 Horizon Discovery Group Company Summary
7.16.2 Horizon Discovery Group Business Overview
7.16.3 Horizon Discovery Group Recombinant DNA Technology Major Product Offerings
7.16.4 Horizon Discovery Group Recombinant DNA Technology Revenue in Global Market (2018-2023)
7.16.5 Horizon Discovery Group Key News & Latest Developments
7.17 New England Biolabs
7.17.1 New England Biolabs Company Summary
7.17.2 New England Biolabs Business Overview
7.17.3 New England Biolabs Recombinant DNA Technology Major Product Offerings
7.17.4 New England Biolabs Recombinant DNA Technology Revenue in Global Market (2018-2023)
7.17.5 New England Biolabs Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
